ID   AP2A_RAT                Reviewed;         437 AA.
AC   P58197;
DT   20-JUN-2001, integrated into UniProtKB/Swiss-Prot.
DT   20-JUN-2001, sequence version 1.
DT   29-MAY-2024, entry version 137.
DE   RecName: Full=Transcription factor AP-2-alpha;
DE            Short=AP2-alpha;
DE   AltName: Full=AP-2 transcription factor;
DE   AltName: Full=Activating enhancer-binding protein 2-alpha;
DE   AltName: Full=Activator protein 2;
DE            Short=AP-2;
GN   Name=Tfap2a; Synonyms=Tcfap2a;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Brain;
RX   PubMed=10847586; DOI=10.1210/mend.14.6.0468;
RA   Li B.-S., Kramer P.R., Zhao W., Ma W., Stenger D.A., Zhang L.;
RT   "Molecular cloning, expression, and characterization of rat homolog of
RT   human AP-2alpha that stimulates neuropeptide Y transcription activity in
RT   response to nerve growth factor.";
RL   Mol. Endocrinol. 14:837-847(2000).
RN   [2]
RP   EFFECT OF ANTIDEPRESSANTS.
RX   PubMed=11205881; DOI=10.1016/s0024-3205(00)00969-3;
RA   Damberg M., Ekblom J., Oreland L.;
RT   "Chronic pharmacological treatment with certain antidepressants alters the
RT   expression and DNA-binding activity of transcription factor AP-2.";
RL   Life Sci. 68:669-678(2000).
CC   -!- FUNCTION: Sequence-specific DNA-binding protein that interacts with
CC       inducible viral and cellular enhancer elements to regulate
CC       transcription of selected genes. AP-2 factors bind to the consensus
CC       sequence 5'-GCCNNNGGC-3' and activate genes involved in a large
CC       spectrum of important biological functions including proper eye, face,
CC       body wall, limb and neural tube development. They also suppress a
CC       number of genes including MCAM/MUC18, C/EBP alpha and c-Myc. AP-2-alpha
CC       is the only AP-2 protein required for early morphogenesis of the lens
CC       vesicle. Together with the CITED2 coactivator, stimulates the PITX2 P1
CC       promoter transcription activation. Associates with chromatin to the
CC       PITX2 P1 promoter region (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Binds DNA as a dimer. Can form homodimers or heterodimers with
CC       other AP-2 family members. Interacts with WWOX. Interacts with CITED4.
CC       Interacts with UBE2I. Interacts with RALBP1 in a complex also
CC       containing EPN1 and NUMB during interphase and mitosis. Interacts with
CC       KCTD1; this interaction represses transcription activation. Interacts
CC       (via C-terminus) with CITED2 (via C-terminus); the interaction
CC       stimulates TFAP2A-transcriptional activation. Interacts (via N-
CC       terminus) with EP300 (via N-terminus); the interaction requires CITED2
CC       (By similarity). Interacts with KCTD15; this interaction inhibits
CC       TFAP2A transcriptional activation (By similarity). {ECO:0000250}.
CC   -!- INTERACTION:
CC       P58197; P49418: AMPH; Xeno; NbExp=2; IntAct=EBI-7069641, EBI-7121510;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: In the brain, highly expressed in the hippocampus,
CC       hypothalamus and cerebral cortex.
CC   -!- INDUCTION: During retinoic acid-mediated differentiation and by nerve
CC       growth factor (NGF). Inhibited by the antidepressants, citalopram and
CC       imipramin.
CC   -!- DOMAIN: The PPxY motif mediates interaction with WWOX. {ECO:0000250}.
CC   -!- PTM: Sumoylated on Lys-10; which inhibits transcriptional activity.
CC       {ECO:0000250}.
CC   -!- MISCELLANEOUS: The antidepressants, citalopram, imipramin and lithium-
CC       chloride decrease the DNA-binding activity.
CC   -!- SIMILARITY: Belongs to the AP-2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   AlphaFoldDB; P58197; -.
DR   SMR; P58197; -.
DR   IntAct; P58197; 2.
DR   MINT; P58197; -.
DR   STRING; 10116.ENSRNOP00000040925; -.
DR   PhosphoSitePlus; P58197; -.
DR   PaxDb; 10116-ENSRNOP00000040925; -.
DR   AGR; RGD:1310267; -.
DR   RGD; 1310267; Tfap2a.
DR   eggNOG; KOG3811; Eukaryota.
DR   InParanoid; P58197; -.
DR   PhylomeDB; P58197; -.
DR   Reactome; R-RNO-8864260; Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors.
DR   Reactome; R-RNO-8866904; Negative regulation of activity of TFAP2 (AP-2) family transcription factors.
DR   Reactome; R-RNO-8866907; Activation of the TFAP2 (AP-2) family of transcription factors.
DR   Reactome; R-RNO-8869496; TFAP2A acts as a transcriptional repressor during retinoic acid induced cell differentiation.
DR   Reactome; R-RNO-9834899; Specification of the neural plate border.
DR   PRO; PR:P58197; -.
DR   Proteomes; UP000002494; Unplaced.
DR   GO; GO:0005905; C:clathrin-coated pit; ISO:RGD.
DR   GO; GO:0005634; C:nucleus; ISO:RGD.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0000987; F:cis-regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0003677; F:DNA binding; ISO:RGD.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISO:RGD.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; ISS:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; ISO:RGD.
DR   GO; GO:0140536; F:nuclear receptor corepressor activity; ISO:RGD.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II transcription regulatory region sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:0043565; F:sequence-specific DNA binding; ISO:RGD.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; ISO:RGD.
DR   GO; GO:0000976; F:transcription cis-regulatory region binding; ISS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; ISO:RGD.
DR   GO; GO:0003714; F:transcription corepressor activity; ISO:RGD.
DR   GO; GO:0021506; P:anterior neuropore closure; ISO:RGD.
DR   GO; GO:0071711; P:basement membrane organization; ISO:RGD.
DR   GO; GO:0060349; P:bone morphogenesis; ISS:UniProtKB.
DR   GO; GO:0008283; P:cell population proliferation; ISO:RGD.
DR   GO; GO:0071281; P:cellular response to iron ion; ISS:UniProtKB.
DR   GO; GO:0061303; P:cornea development in camera-type eye; ISO:RGD.
DR   GO; GO:0010172; P:embryonic body morphogenesis; ISO:RGD.
DR   GO; GO:0048596; P:embryonic camera-type eye morphogenesis; ISO:RGD.
DR   GO; GO:0048701; P:embryonic cranial skeleton morphogenesis; ISS:UniProtKB.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; ISS:UniProtKB.
DR   GO; GO:0009880; P:embryonic pattern specification; ISO:RGD.
DR   GO; GO:0007173; P:epidermal growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0048730; P:epidermis morphogenesis; ISO:RGD.
DR   GO; GO:0061029; P:eyelid development in camera-type eye; ISS:UniProtKB.
DR   GO; GO:0060325; P:face morphogenesis; ISO:RGD.
DR   GO; GO:0010761; P:fibroblast migration; ISO:RGD.
DR   GO; GO:0021884; P:forebrain neuron development; ISO:RGD.
DR   GO; GO:0035136; P:forelimb morphogenesis; ISO:RGD.
DR   GO; GO:0042472; P:inner ear morphogenesis; ISS:UniProtKB.
DR   GO; GO:0003334; P:keratinocyte development; ISO:RGD.
DR   GO; GO:0001822; P:kidney development; ISS:UniProtKB.
DR   GO; GO:0060235; P:lens induction in camera-type eye; ISO:RGD.
DR   GO; GO:0002089; P:lens morphogenesis in camera-type eye; ISO:RGD.
DR   GO; GO:0072210; P:metanephric nephron development; ISO:RGD.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; ISO:RGD.
DR   GO; GO:0045892; P:negative regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; ISO:RGD.
DR   GO; GO:0043524; P:negative regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:2000378; P:negative regulation of reactive oxygen species metabolic process; ISS:UniProtKB.
DR   GO; GO:0010944; P:negative regulation of transcription by competitive promoter binding; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; ISO:RGD.
DR   GO; GO:0014032; P:neural crest cell development; ISO:RGD.
DR   GO; GO:0001843; P:neural tube closure; ISO:RGD.
DR   GO; GO:0051402; P:neuron apoptotic process; ISO:RGD.
DR   GO; GO:0021623; P:oculomotor nerve formation; ISS:UniProtKB.
DR   GO; GO:0003409; P:optic cup structural organization; ISS:UniProtKB.
DR   GO; GO:0003404; P:optic vesicle morphogenesis; ISS:UniProtKB.
DR   GO; GO:0003151; P:outflow tract morphogenesis; ISO:RGD.
DR   GO; GO:0030501; P:positive regulation of bone mineralization; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of DNA-templated transcription; ISS:UniProtKB.
DR   GO; GO:0010763; P:positive regulation of fibroblast migration; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISO:RGD.
DR   GO; GO:0070172; P:positive regulation of tooth mineralization; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:RGD.
DR   GO; GO:0045595; P:regulation of cell differentiation; ISO:RGD.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IBA:GO_Central.
DR   GO; GO:0006355; P:regulation of DNA-templated transcription; ISO:RGD.
DR   GO; GO:0045664; P:regulation of neuron differentiation; ISO:RGD.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0032496; P:response to lipopolysaccharide; IDA:RGD.
DR   GO; GO:0010842; P:retina layer formation; ISO:RGD.
DR   GO; GO:0060021; P:roof of mouth development; ISS:UniProtKB.
DR   GO; GO:0014044; P:Schwann cell development; IEP:RGD.
DR   GO; GO:0007423; P:sensory organ development; ISO:RGD.
DR   GO; GO:0007605; P:sensory perception of sound; ISS:UniProtKB.
DR   GO; GO:0048705; P:skeletal system morphogenesis; ISO:RGD.
DR   GO; GO:0043588; P:skin development; ISO:RGD.
DR   GO; GO:0048485; P:sympathetic nervous system development; ISO:RGD.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; ISO:RGD.
DR   GO; GO:0021559; P:trigeminal nerve development; ISS:UniProtKB.
DR   InterPro; IPR004979; TF_AP2.
DR   InterPro; IPR008121; TF_AP2_alpha_N.
DR   InterPro; IPR013854; TF_AP2_C.
DR   PANTHER; PTHR10812; TRANSCRIPTION FACTOR AP-2; 1.
DR   PANTHER; PTHR10812:SF8; TRANSCRIPTION FACTOR AP-2-ALPHA; 1.
DR   Pfam; PF03299; TF_AP-2; 1.
DR   PRINTS; PR01749; AP2ATNSCPFCT.
DR   PRINTS; PR01748; AP2TNSCPFCT.
PE   1: Evidence at protein level;
KW   Activator; DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..437
FT                   /note="Transcription factor AP-2-alpha"
FT                   /id="PRO_0000184798"
FT   REGION          14..107
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          280..410
FT                   /note="H-S-H (helix-span-helix), dimerization"
FT                   /evidence="ECO:0000250|UniProtKB:P05549"
FT   REGION          414..437
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOTIF           57..62
FT                   /note="PPxY motif"
FT   COMPBIAS        23..48
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        49..67
FT                   /note="Pro residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        68..107
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   MOD_RES         239
FT                   /note="Phosphoserine; by PKA"
FT                   /evidence="ECO:0000250|UniProtKB:P05549"
FT   CROSSLNK        10
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO); alternate"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        10
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P05549"
FT   CROSSLNK        177
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P05549"
FT   CROSSLNK        184
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000250|UniProtKB:P05549"
SQ   SEQUENCE   437 AA;  47947 MW;  EB8C53D07DCCFE3C CRC64;
     MLWKLTDNIK YEDCEDRHDG TSNGTARLPQ LGTVGQSPYT SAPPLSHTPN ADFQPPYFPP
     PYQPIYPQSQ DPYSHVNDPY SLNPLHAQPQ PQHPGWPGQR QSQESGLLHT HRGLPHQLSG
     LDPRRDYRRH EDLLHGPHGL GSGLGDLPIH SLPHAIEDVP HVEDPGINIP DQTVIKKGPV
     SLSKSNSNAV SAIPINKDNL FGGVVNPNEV FCSVPGRLSL LSSTSKYKVT VAEVQRRLSS
     PECLNASLLG GVLRRAKSKN GGRSLREKLD KIGLNLPAGR RKAANVTLLT SLVEGEAVHL
     ARDFGYVCET EFPAKAVAEF LNRQHSDPNE QVARKNMLLA TKQICKEFTD LLAQDRSPLG
     NSRPNPILEP GIQSCLTHFN LISHGFGSPA VCAAVTALQN YLTEALKAMD KMYLSNNPNS
     HTDNSAKSSD KEEKHRK
//
